Similar articles for PMID: 12451472

Year	Number of Results
1982	2
1983	1
1985	1
1994	1
1996	1
1997	3
2000	8
2001	3
2002	6
2003	5
2004	4
2005	1
2006	5
2007	5
2008	2
2009	1
2010	4
2011	5
2012	1
2013	3
2014	4
2015	2
2016	2
2018	2
2019	1
2020	2
2021	1
2022	1
2023	1
2024	0

1

The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.

Ferrero JM, Chamorey E, Magné N, Leccia F, Largillier R, Namer M, Milano G. Ferrero JM, et al. Cancer Chemother Pharmacol. 2002 Dec;50(6):459-64. doi: 10.1007/s00280-002-0519-2. Epub 2002 Sep 19. Cancer Chemother Pharmacol. 2002. PMID: 12451472 Clinical Trial.

2

A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.

Delozier T, Guastalla JP, Yovine A, Levy C, Chollet P, Mousseau M, Delva R, Coeffic D, Vannetzel JM, Zazzi ES, Brienza S, Cvitkovic E. Delozier T, et al. Anticancer Drugs. 2006 Oct;17(9):1067-73. doi: 10.1097/01.cad.0000231475.77159.aa. Anticancer Drugs. 2006. PMID: 17001180 Clinical Trial.

3

Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.

Delva R, Pienkowski T, Tubiana N, Vanhoefer U, Longerey B, Douville I. Delva R, et al. Cancer Chemother Pharmacol. 2007 May;59(6):703-9. doi: 10.1007/s00280-006-0324-4. Epub 2006 Sep 22. Cancer Chemother Pharmacol. 2007. PMID: 17021821 Clinical Trial.

4

Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.

Pieńkowski T, Jagiello-Gruszfeld A. Pieńkowski T, et al. Int J Clin Pharmacol Res. 2001;21(3-4):111-7. Int J Clin Pharmacol Res. 2001. PMID: 12067140

5

A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.

Dittrich C, Petruzelka L, Vodvarka P, Gneist M, Janku F, Kysela T, Melemed A, Latz J, Simms L, Krejcy K. Dittrich C, et al. Clin Cancer Res. 2006 Dec 1;12(23):7071-8. doi: 10.1158/1078-0432.CCR-05-2829. Clin Cancer Res. 2006. PMID: 17145830 Clinical Trial.

6

A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.

O'connor T, Rustum Y, Levine E, Creaven P. O'connor T, et al. Cancer Chemother Pharmacol. 2008 Jan;61(1):125-31. doi: 10.1007/s00280-007-0456-1. Epub 2007 Apr 11. Cancer Chemother Pharmacol. 2008. PMID: 17426973 Clinical Trial.

7

Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.

Rezai K, Urien S, Isambert N, Roche H, Dieras V, Berille J, Bonneterre J, Brain E, Lokiec F. Rezai K, et al. Cancer Chemother Pharmacol. 2011 Dec;68(6):1529-36. doi: 10.1007/s00280-011-1650-8. Epub 2011 Apr 26. Cancer Chemother Pharmacol. 2011. PMID: 21519841

8

Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.

Supko JG, Eder JP Jr, Ryan DP, Seiden MV, Lynch TJ, Amrein PC, Kufe DW, Clark JW. Supko JG, et al. Clin Cancer Res. 2003 Nov 1;9(14):5178-86. Clin Cancer Res. 2003. PMID: 14613997 Clinical Trial.

9

Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).

Galetta D, Giotta F, Rosati G, Gebbia V, Manzione L, Di Bisceglie M, Borsellino N, Colucci G. Galetta D, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4445-9. Anticancer Res. 2005. PMID: 16334124 Free article. Clinical Trial.

10

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.

Ardavanis A, Mavroudis D, Kalbakis K, Malamos N, Syrigos K, Vamvakas L, Kotsakis A, Kentepozidis N, Kouroussis C, Agelaki S, Georgoulias V; Breast Cancer Committee of the Hellenic Oncology Research Group. Ardavanis A, et al. Cancer Chemother Pharmacol. 2006 Dec;58(6):742-8. doi: 10.1007/s00280-006-0236-3. Epub 2006 May 23. Cancer Chemother Pharmacol. 2006. PMID: 16718470 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year